SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
BAX

Baxter International Inc (New York Stock Exchange:BAX)

US · Delayed Price · Currency is USD
Also listed: 0QK8.L, BAX.SWHealthcare · Medical - Instruments & Supplies
$25.39+$0.00 (+0.00%)
 
Market cap
$13.1B
Insider Score
Health Score
Analyst consensus
Listed since
Oct 27, 1981
Website
Market Cap$13.14B+39.7%
Revenue (ttm)$11.61B+5.3%
Net Income-$723.00M-112.0%
EPS-$1.38-109.2%
Shares Out517.35M
PE Ration/a
Forward PE12.44
Dividend$0.04(0.16%)
Ex-Dividend DateNov 27, 2026
Volume4,318,244
Open$25.43
Previous Close$25.39
Day's Range$25.25 - $26.07
52-Week Range$15.73 - $30.00
Beta0.67
AnalystsHold
Price Target$23.83(-6.14%)
Earnings DateFeb 11, 2027

About BAX

Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devices vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.

Address
One Baxter Parkway, Deerfield, IL, 60015, US
Market Cap
13.14 billion
Employees
37,500
Industrial Classification
Medical - Instruments & Supplies

Analyst consensus

Hold
0 Buy3 Hold1 SellAvg target $22.83 (-10.1%)

4 firms rating BAX in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From BAX’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
+0.00%
5 Days
-1.55%
1 Month
-1.01%
6 Months
+32.38%
1 Year
+39.66%

$BAX stock is featured in our Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of BAX by members of U.S. Congress

Michael T. McCaulHouse / RPurchase$15.00K – $50.00KMar 23, 2026
Michael T. McCaulHouse / RPurchase$50.00K – $100.00KJan 13, 2026
Lisa C. McClainHouse / RSale$1.00K – $15.00KOct 31, 2025
Lisa C. McClainHouse / RPurchase$1.00K – $15.00KOct 30, 2025
Lisa C. McClainHouse / RSale$1.00K – $15.00KOct 30, 2025
Lisa C. McClainHouse / RPurchase$1.00K – $15.00KSep 25, 2025
Lisa C. McClainHouse / RSale$1.00K – $15.00KAug 4, 2025
Lisa C. McClainHouse / RPurchase$1.00K – $15.00KJul 22, 2025

Recently reported changes in BAX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by BAX's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

BAX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

BAX Revenue by Segment or Geography

$2.91BTotal
Medical Products & Therapies$2.10B72.28%
Healthcare Systems & Technologies$806.00M27.72%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New BAX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BAX from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in BAX

VOOVanguard S&P 500 ETF$316.17M
VTIVanguard Morningstar Total Stock Market ETF$297.98M
VBVanguard Morningstar Small-Cap ETF$266.57M
RSPInvesco S&P 500 Equal Weight ETF$212.89M
IVViShares Core S&P 500 ETF$176.84M
SPYState Street SPDR S&P 500 ETF$161.00M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from BAX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
62% of score
52
News & Sentiment
38% of score
60

News check: One substantive BAX headline emphasizing long-term investment appeal; market report mentions BAX as competitor in gynecological equipment segment.

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

PZLVPzena U.S. Large Cap Value ETF5.12%
ADPVAdaptiv Select ETF3.97%
SCIUGlobal X Scientific Beta US ETF2.70%
CVGDCresAlta Global Dividend ETF2.30%
MDEVFirst Trust Indxx Medical Devices ETF2.02%
IHIiShares U.S. Medical Devices ETF1.68%
XHEState Street SPDR S&P Health Care Equipment ETF1.60%
RSPHInvesco S&P 500 Equal Weight Health Care ETF1.58%
RYHInvesco S&P 500 Equal Weight Health Care ETF1.58%
FPAGFPA Global Equity ETF1.55%
BLCViShares Large Cap Value Active ETF1.24%
ZUH.TOBMO Equal Weight US Health Care Hedged to CAD Index ETF1.08%

Weight is the stock’s share of each fund’s holdings.